Literature DB >> 30551506

RETRACTED: Icariin inhibits cell proliferation, migration and invasion by down-regulation of microRNA-625-3p in thyroid cancer cells.

Lei Fang1, Wei Xu1, Dedi Kong2.   

Abstract

This article has been retracted: please see Elsevier Policy on Article Withdrawal (https://www.elsevier.com/about/our-business/policies/article-withdrawal). This article has been retracted at the request of the Editor-in-Chief. Given the comments of Dr Elisabeth Bik regarding this article “… the Western blot bands in all 400+ papers are all very regularly spaced and have a smooth appearance in the shape of a dumbbell or tadpole, without any of the usual smudges or stains. All bands are placed on similar looking backgrounds, suggesting they were copy/pasted from other sources, or computer generated”, the journal requested the authors to provide the raw data. However, the authors were not able to fulfil this request and therefore the Editor-in-Chief decided to retract the article.
Copyright © 2018. Published by Elsevier Masson SAS.

Entities:  

Keywords:  Icariin; MEK/ERK; PI3K/AKT; Thyroid cancer; microRNA-625-3p

Mesh:

Substances:

Year:  2018        PMID: 30551506     DOI: 10.1016/j.biopha.2018.04.012

Source DB:  PubMed          Journal:  Biomed Pharmacother        ISSN: 0753-3322            Impact factor:   6.529


  14 in total

Review 1.  Molecular mechanisms regulating the pharmacological actions of icariin with special focus on PI3K-AKT and Nrf-2 signaling pathways.

Authors:  Aanchal Verma; Kritika Aggarwal; Ritik Agrawal; Kajal Pradhan; Ahsas Goyal
Journal:  Mol Biol Rep       Date:  2022-08-08       Impact factor: 2.742

2.  Relief Effects of Icariin on Inflammation-Induced Decrease of Tight Junctions in Intestinal Epithelial Cells.

Authors:  Yanli Li; Jie Liu; Pawin Pongkorpsakol; Zhengguo Xiong; Li Li; Xuemei Jiang; Haixia Zhao; Ding Yuan; Changcheng Zhang; Yuhui Guo; Yaoyan Dun
Journal:  Front Pharmacol       Date:  2022-06-08       Impact factor: 5.988

3.  Current update on anticancer effects of icariin: A journey of the last ten years.

Authors:  Mukta Gupta; Yachana Mishra; Vijay Mishra; Murtaza M Tambuwala
Journal:  EXCLI J       Date:  2022-04-06       Impact factor: 4.022

Review 4.  Dietary Phytoestrogens and Their Metabolites as Epigenetic Modulators with Impact on Human Health.

Authors:  Victor Stefan Ionescu; Alexandra Popa; Andrei Alexandru; Emilia Manole; Mihaela Neagu; Sevinci Pop
Journal:  Antioxidants (Basel)       Date:  2021-11-26

5.  Icariin inhibits the malignant progression of lung cancer by affecting the PI3K/Akt pathway through the miR‑205‑5p/PTEN axis.

Authors:  Fengjie Zhu; Zhe Ren
Journal:  Oncol Rep       Date:  2022-05-06       Impact factor: 4.136

6.  Induction of oxidative stress, apoptosis and DNA damage by koumine in Tetrahymena thermophila.

Authors:  Qiao Ye; Chaonan Zhang; Zhenlu Wang; Yongyong Feng; Aiguo Zhou; Shaolin Xie; Qiong Xiang; Enfeng Song; Jixing Zou
Journal:  PLoS One       Date:  2019-02-12       Impact factor: 3.240

7.  Icariin induces apoptosis by suppressing autophagy in tamoxifen-resistant breast cancer cell line MCF-7/TAM.

Authors:  Xia Cheng; Shirui Tan; Feifei Duan; Qingqing Yuan; Qingrong Li; Gang Deng
Journal:  Breast Cancer       Date:  2019-06-06       Impact factor: 4.239

8.  Icariin Mitigates the Growth and Invasion Ability of Human Oral Squamous Cell Carcinoma via Inhibiting Toll-Like Receptor 4 and Phosphorylation of NF-κB P65.

Authors:  Ke Lei; Bing Ma; Ping Shi; Che Jin; Tan Ling; Longjiang Li; Xiangyi He; Lunchang Wang
Journal:  Onco Targets Ther       Date:  2020-01-10       Impact factor: 4.147

9.  Vimentin as a target for the treatment of COVID-19.

Authors:  Zhenlin Li; Denise Paulin; Patrick Lacolley; Dario Coletti; Onnik Agbulut
Journal:  BMJ Open Respir Res       Date:  2020-09

Review 10.  Herbal Active Ingredients: An Emerging Potential for the Prevention and Treatment of Papillary Thyroid Carcinoma.

Authors:  Yang Yang; Qin Chen; Wen-Ying Yu; Huan-Huan Zhang; Yu-Sen Zhong; Song-Zhao Zhang; Jia-Feng Wang; Chen-Huan Yu
Journal:  Biomed Res Int       Date:  2020-01-31       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.